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Objectives: We developed an outcome indicator
based on the finding that complications often prolong
the patient’s hospital stay. A higher percentage of
patients with an unexpectedly long length of stay
(UL-LOS) compared to the national average may
indicate shortcomings in patient safety. We explored
the utility of the UL-LOS indicator.
Setting: We used data of 61 Dutch hospitals. In total
these hospitals had 1 400 000 clinical discharges in
2011.
Participants: The indicator is based on the
percentage of patients with a prolonged length of stay
of more than 50% of the expected length of stay and
calculated among survivors.
Interventions: No interventions were made.
Outcome measures: The outcome measures were the
variability of the indicator across hospitals, the stability
over time, the correlation between the UL-LOS and
standardised mortality and the influence on the indicator
of hospitals that did have problems discharging their
patients to other health services such as nursing homes.
Results: In order to compare hospitals properly the
expected length of stay was computed based on
comparison with benchmark populations. The
standardisation was based on patients’ age, primary
diagnosis and main procedure. The UL-LOS indicator
showed considerable variability between the Dutch
hospitals: from 8.6% to 20.1% in 2011. The outcomes
had relatively small CIs since they were based on large
numbers of patients. The stability of the indicator over
time was quite high. The indicator had a significant
positive correlation with the standardised mortality
(r=0.44 (p<0.001)), and no significant correlation with
the percentage of patients that was discharged to other
facilities than other hospitals and home (r=−0.15
(p>0.05)).
Conclusions: The UL-LOS indicator is a useful
addition to other patient safety indicators by revealing
variation between hospitals and areas of possible
patient safety improvement.
BACKGROUND
For about 10 years, improving quality of care
based on outcome indicators is seen as an
essential component in optimising safety in
healthcare. In the Netherlands, like in many
other countries, a large number of indicators
have been developed and introduced to
monitor the quality and safety of hospital
care.1–3 Many of these indicators concern a
speciﬁc patient group. There are also some
general quality indicators that concern the
whole hospital. The most important ones are:
unexpectedly long length of stay (UL-LOS);
unplanned readmissions and higher than
expected mortality (measured by the Hospital
Standardised Mortality Rate, HSMR).
According to the Dutch Healthcare
Inspectorate (IGZ) these are especially of
interest for identifying general patient safety
risks in hospital care. It is important to
measure all three indicators since a degree
of substitution—or competition—between
them is possible. For example, if a hospital
tries to discharge patients too quickly, this
policy could result in a higher percentage of
unplanned readmissions. The indicator for
unplanned readmissions, already used in
several countries such as the UK and the
USA,4–7 is not yet available in the
Netherlands. The HSMR has already been
available in Dutch hospitals since 2006.8
Strengths and limitations of this study
▪ This study provides a hospital-wide indicator that
can be used in addition to mortality and
readmission rates in order to identify potential
safety risks.
▪ The current indicator adjusts for differences in
age, principal diagnosis and procedures. But
there are probably more variables involved in a
prolonged hospital stay.
▪ The indicator currently ‘counts’ all patients from
whom the actual length of stay exceeds the
expected duration by 50% or more. It needs to
be studied whether this cut-off point can be set
separately for each patient group.
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The UL-LOS did not exist until some years ago the IGZ
was looking for more general patient safety indicators.
Research shows that hospital adverse events often result
in a longer length of stay.9–22 In several other studies on
adverse events, a long length of stay was used as an
important trigger for selecting medical records.23–25 So,
if complications often prolong the patient’s hospital stay,
could an outcome indicator be developed such as the
percentage of patients with a UL-LOS compared to the
national average? Such an outcome may indicate short-
comings in the quality or safety of care delivered by the
hospital.
As far back as 1999, Silber et al26 had already pub-
lished research about an indicator called ‘conditional
length of stay’. This was based on length of stay data and
took into account the fact that patient stays tend to
become prolonged after complications. They developed
this indicator by testing if length of stay distributions
display an ‘extended’ pattern of decreasing hazards after
a transition point. This would suggest that ‘the longer a
patient has stayed in the hospital, the longer a patient
will likely stay in the hospital’. Or, alternatively, there is
the possibility that ‘the longer a patient has stayed in the
hospital, the faster a patient will likely be discharged
from the hospital’.
On the basis of these former ideas, the IGZ decided
to introduce such an indicator of prolonged length of
stay. In the current paper we explore the utility of this
indicator by measuring the variability of the indicator
across hospitals and the stability over time. We also
examine the correlation between the two existing indica-
tors of the model: the UL-LOS and the HSMR, as they
are both supposed to be an indicator of risk of unsafe
care. The HSMR focuses by deﬁnition on adverse events
leading to hospital mortality. The UL-LOS is calculated
among survivors and involves a much wider range of
adverse events. It includes all adverse events leading to a
substantial prolonged length of stay. We expected a posi-
tive relationship between the two indicators, as reduced
quality of care leads to more adverse events, and more
adverse events lead to more patients with prolonged hos-
pitalisation as well as to more deaths.
METHODS
Data
To calculate the UL-LOS we used data that were rou-
tinely registered for administrative purposes. Using an
existing registration minimalises extra registration
burden. These databases can be used to predict risks
with similar discrimination to clinical databases.27 The
National Medical Registration (LMR) has already been
existing for 50 years in the Netherlands and contains
data of hospital admissions including medical data such
as diagnosis and surgical procedures as well as patient-
speciﬁc data such as age and hospital stay.28 For the
UL-LOS we especially used the variable ‘expected length
of stay’, which is generated by indirect standardisation
based on the following three patient characteristics,
which are the most important characteristics for stand-
ardisation of length of stay data29:
▸ Age: divided into ﬁve categories: 0, 1–14, 15–44, 45–
64, 65+ years.
▸ Primary diagnosis: this is the main diagnosis that led
to the admission; it includes about 1000 diagnoses
classiﬁed by the ICD9 in three digits.
▸ Morbidity group: morbidity groups mainly divide
patients with or without procedures. For patients with
procedures the morbidity groups are made by unique
combinations of a diagnosis and one or more proce-
dures. On average it includes ﬁve procedure groups.
Procedures are classiﬁed by the Dutch Classiﬁcation
System of Procedures.
Together these three parameters produced
5×1000×5=25 000 cells. Every year the national mean
length of stay of each cell is taken as the expected
length of stay for the patients with characteristics that
belong to the same cell.
Definition
We used the expected length of stay to deﬁne an
outcome indicator that suited the purpose of identifying
adverse events. We used former research to choose a
single cut-off percentage prolonged length of stay across
all diagnoses and case mixes to distinguish between
‘normal’ variation in length of stay and variation in hos-
pital stay that might be caused by complications and
other patient safety issues.30 In literature we found the
use of a threshold of 75%,31 32 which in fact was arbitrar-
ily chosen. We formulated the indicator ‘UL-LOS’ as the
percentage of clinically admitted patients with an actual
hospital stay that was more than 50% longer than
expected.2 We excluded from this indicator patients who
died in hospital. We excluded these patients because of
the interrelationship between length of stay and mortal-
ity which makes it difﬁcult to interpret length of stay
data if non-survivors are included.33
We used a threshold of 50% for two reasons:
1. We especially wanted to include patients who stayed
longer because of complications and adverse events,
and not patients who just stayed a little bit longer in hos-
pital because of variations in efﬁciency (see ﬁgure 1).
The percentage should not be too small.
2. We analysed for the Netherlands the percentages of
patients with a longer than expected length of stay
Figure 1 Components of length of stay (LOS); UL-LOS,
unexpectedly long length of stay.
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for 10 different threshold groups between 0% and
100%. We found that the percentages after the
threshold of 50% seem to dip beneath 2% (see
online supplementary annex 1).
In combination with our ﬁrst experiences with case
studies that showed that the number of adverse events
clearly increased from a longer than expected length of
stay of 50% or more,30 we decided to use the threshold
of 50% in order not to exclude too many patients with
adverse events. In fact the threshold depends on what
speciﬁcity or what false-positive rates you are willing to
accept. With a threshold of 50% we expect to ﬁnd a
higher number of adverse events than with a threshold
of 75%, but we expect the proportion of adverse events
will be lower. A higher threshold would mean more efﬁ-
ciency in ﬁnding adverse events.
Sample
We selected hospitals for which the indicator could be
calculated. Hospitals had to participate in the LMR not
only by registration of the diagnoses of clinical patients
but also the procedures. For our study, we used data
from the year 2011 of 61 of all 90 Dutch hospitals:
▸ Six hospitals were excluded because they did not par-
ticipate at all.
▸ Five hospitals were excluded because they partici-
pated for less than 50% of the year. The group of 79
hospitals after this step consisted of 73 hospitals that
participated the whole year, 4 hospitals participating
for 50–60% of the year and 2 hospitals participating
for 70–80% of the year. All these six hospitals partici-
pating for 50–80% coded at least 6 months
sequentially.
▸ Eighteen hospitals were excluded because they did
not register the procedures in the LMR. Among
these hospitals were general and tertiary teaching
hospitals, and they did not differ in size or region
from the hospitals that could be included in the
study.
See the ﬂow chart in ﬁgure 2.
To optimise the comparability of hospitals, we strati-
ﬁed the sample into three groups: 32 general hospitals,
21 tertiary teaching hospitals (TTHs) and 8 university
medical centres (UMCs). Within these groups, size,
degree of specialisation, ﬁnancing system and complex-
ity of patients are comparable.34–36
Analyses
To explore the utility of the indicator, we measured the
variability of the indicator across hospitals and the stabil-
ity over time. To ﬁnd out whether the indicator is stable
over time, we determined the correlation between the
percentages per hospital in ‘2008 and 2009’, ‘2009 and
2010’, ‘2010 and 2011’ and ‘2008 and 2011’.
In order to analyse whether the indicator could identify
risks of unsafe care, we correlated the results of the UL-LOS
with the HSMRs for the year 2011. Therefore we calculated
the Pearson correlations and the two-tailed signiﬁcance
between the UL-LOS and the HSMRs. The HSMR consists
of the quotients of observed mortality and expected mortal-
ity in 50 diagnostic groups (Clinical Classiﬁcation System;
CCS) in which 80% of all hospital mortality took place. The
expected mortality was based on the following character-
istics of the patients: age, sex, CCS-subgroup, comorbidity
(Charlson index), urgency, social deprivation, source organ-
isation type, month and year.
As with the UL-LOS, the HSMR could only be calcu-
lated for hospitals that participated in the LMR. Some
additional criteria were used in order to optimise the
reliability of the standardisation. To be included in the
HSMR, hospitals had to:
▸ Avoid the use of vague diagnostic codes (this had to
be less than 2% of the admissions);
▸ Perform an adequate registration of the urgency of
the admission (more than 30% of the admissions had
to be marked as urgent);
▸ Perform an adequate registration of the comorbidity
of patients (the mean number of secondary diagnosis
per admission had to be more than 0.5).
In addition, the HSMR had to count for more than
70% of all deaths in hospital, and the hospital had to
have more than 50 expected deaths per year. All these
additional criteria resulted in 58 hospitals remaining for
our correlation study between UL-LOS and HSMR for
the year 2011, see the ﬂow chart in ﬁgure 2.
We investigated whether the UL-LOS indicator (and
the HSMR) might be inﬂuenced by hospitals that, for
local resource reasons, do not have as much access to
nursing home beds, home care support, palliative care
or hospices, and thus keep more of these patients in the
hospital rather than discharging them to stay or die else-
where. We addressed this by two different analyses:
1. We calculated the percentage of patients discharged
to other facilities than other hospitals and home.
This percentage approximately gives the extent to
which hospitals are able to discharge patients for
long-term or palliative care.
2. We re-ran the analysis restricted to diagnostic categor-
ies where most patients are discharged home without
a diagnosis for which one might expect a palliative
approach. To select this group, we excluded all CCS
groups37 with carcinoma.
RESULTS
In ﬁgure 3 the percentage of UL-LOS is given for the 61
hospitals in our study. The ﬁgure also shows the 95%
conﬁdence limits. A distinction has been made between
general hospitals, TTHs and UMCs. The national
median of the percentage of clinical admissions with a
UL-LOS was 11.3%. The UMCs had a relatively high
score on this indicator compared with the TTHs and
general hospitals.
For the UMCs the variation of the percentages was
between 12% and 20.1%, with a median of 15.1%. The
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TTHs varied between 9.4% and 15%, with a median of
11.3%. For the general hospitals the variation was
between 8.6% and 16%, with a median of 11.1%. With
an independent sample t test we found no signiﬁcant
difference between TTHs and general hospitals, t(53)
=0.16; p=0.88.
To explore the stability of the indicator, we calculated
the correlation of the indicator between two subsequent
years. The R2 between 2008 and 2009 was 0.89, between
2009 and 2010 it was 0.86 and between 2010 and 2011 it
was 0.90. Figure 4 shows the correlation between 2008
and 2011. The R2 between these years was 0.70.
Table 1 shows for the year 2011 for each hospital the
UL-LOS indicator and the HSMR in two ways: with and
without patients with carcinoma. This table also shows
for each hospital the percentage of patients admitted to
other destinations than home or other hospitals. There
was no substantial difference in the outcome of the
UL-LOS indicator calculated with or without patients
with carcinomas. The correlation of the UL-LOS with/
without carcinomas was 1.00; correlation of the HSMR
with/without carcinomas was 0.96. The Pearson correl-
ation between the UL-LOS indicator and the HSMR
with all diagnosis groups was 0.44 (p<0.001) and with
Figure 2 Flow chart hospitals in
correlation study between
unexpectedly long length of stay
(UL-LOS) and Hospital
Standardised Mortality Rate
(HSMR) for the year 2011; LMR,
National Medical Registration.
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carcinoma excluded 0.52 (p<0.001). We found no sig-
niﬁcant correlation between the UL-LOS indicator and
the score on discharging patients. The Pearson correl-
ation between the UL-LOS and discharging palliative
patients with all diagnosis groups was −0.15 (p>0.05)
and with carcinoma excluded −0.16 (p>0.05).
DISCUSSION
In this paper, we described the development of a patient
safety indicator for Dutch hospitals that, to the best of
our knowledge, has not been described in the literature
until now. The indicator is deﬁned as the percentage of
clinically admitted patients with an actual hospital stay
that was more than 50% longer than expected. The indi-
cator showed considerable variability between the Dutch
hospitals: from 8.6% to 20.1% in 2011. It also showed
serious variation within homogenous groups of hospitals.
The stability of the indicator over 3 years was quite high
and the indicator had a signiﬁcant positive correlation
with the HSMR. This indicates that the hospitals with
more patients with a UL-LOS were also the hospitals
with higher standardised mortality. This might support
our hypothesis that suboptimal quality of care may both
lead to more patients with a UL-LOS as well as to more
mortality than expected. More research is needed to
determine the validity of the UL-LOS indicator.
Especially record reviewing to look for adverse events is
needed for a stronger support of our hypothesis. In add-
ition to this an indicator for readmissions should be
added to the indicator framework and should be a
subject for future research.
The strong correlation between the UL-LOS with and
without carcinomas, and the low correlation between
UL-LOS and discharging patients, seem to indicate that
the UL-LOS is not inﬂuenced by differences between
hospitals in the ability to admit patients to next care
facilities. This might be important for hospitals in realis-
ing that high percentages of patients with an UL-LOS
will probably not be caused by opportunities of dischar-
ging patients.
In terms of evaluation of care it is becoming increas-
ingly common for hospitals to study patient records retro-
spectively, especially in cases of deceased patients.25 26
This indicator might be a good research tool to identify
records of patients who were discharged alive. This could
lead to opportunities for improvements that are different
from those based on patient record-reviewing after death.
The indicator provides insight into the percentage of
patients that stayed at least 50% longer than expected.
The assumption is that in this group a relatively large
number of patients have had to deal with unexpected
developments in their disease, resulting in complications
that cause a prolonged stay. It could be much more
effective for hospitals to review records of hospital
admissions selected by this indicator compared to ran-
domly selected patient records. Reviewing records takes
considerable time and by using this indicator for selec-
tion, time could be saved by reviewing fewer records
from which more lessons might be learnt.30
Hospital management might also have ﬁnancial
reasons to be interested in the indicator in addition to
the quality and safety aspects of the UL-LOS indicator.
Having a longer than expected length of stay, costs
Figure 3 Percentage of
admissions with an unexpectedly
long length of stay (UL-LOS) for
the hospitals in our study, defined
by type of hospital: general
hospitals (n=32), tertiary teaching
hospitals (n=21) and University
Medical Centres (n=8); National
Medical Registration (LMR) 2011,
I=95% CI = admissions with
UL-LOS 2011 (%).
Figure 4 Correlation between the years 2008 and 2011 for
the percentage of admissions with an unexpectedly long
length of stay (UL-LOS) per hospital. National Medical
Registration (LMR) 2008 and 2011 (n=57).
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Table 1 Sixty-one hospitals with their UL-LOS and HSMR in two ways: with and without patients with carcinoma and the
percentage of patients admitted to other destinations than home or other hospital; 2011
Hospital number
Total hospitals Carcinoma excluded Admissions to other destinations
than home or other hospital (%)UL-LOS 2011(%) HSMR 2011 UL-LOS 2011(%) HSMR 2011
1 20.1 117 20.3 128 1.4
2 18.7 Not available 18.8 Not available 0.6
3 17.8 115 17.8 118 0.5
4 16.0 147 15.5 145 3.4
5 15.6 118 15.6 128 1.8
6 15.6 129 15.8 133 1.4
7 15.0 100 15.0 101 4.7
8 14.7 101 14.5 103 0.9
9 14.7 Not available 14.6 Not available 2.5
10 14.7 101 14.6 100 4.3
11 13.9 93 13.6 98 1.7
12 13.6 108 13.4 105 3.2
13 13.4 113 13.3 109 2.3
14 13.4 106 13.6 104 Not available
15 13.2 71 13.0 70 2.2
16 13.0 107 12.9 112 1.2
17 12.8 112 12.6 112 4.5
18 12.7 100 12.7 101 1.7
19 12.4 108 12.2 107 2.2
20 12.4 65 12.1 64 3.1
21 12.4 106 12.2 102 2.3
22 12.3 92 12.1 88 2.1
23 12.2 70 12.1 72 1.4
24 12.1 94 12.1 86 2.1
25 12.0 91 12.3 96 2.7
26 11.7 104 11.6 102 0.2
27 11.5 78 11.5 82 3.4
28 11.5 116 11.4 111 1.2
29 11.4 115 11.5 114 2.6
30 11.4 101 11.1 105 1.0
31 11.3 101 11.0 90 0.8
32 11.3 94 11.3 96 2.8
33 11.3 94 11.3 98 2.8
34 11.3 107 11.3 115 2.3
35 11.2 91 11.2 91 3.3
36 11.2 83 11.1 80 0.6
37 11.1 104 11.3 106 1.5
38 11.1 114 10.8 111 1.8
39 11.0 103 10.9 108 2.4
40 11.0 93 10.7 91 2.2
41 10.9 114 10.9 114 2.4
42 10.9 106 10.8 103 2.9
43 10.9 107 10.8 105 2.0
44 10.9 104 10.5 101 2.5
45 10.7 110 10.6 101 3.4
46 10.7 81 10.6 79 2.4
47 10.6 100 10.4 99 1.6
48 10.6 99 10.6 95 2.4
49 10.6 Not available 10.2 Not available 2.2
50 10.5 93 10.3 95 2.3
51 10.4 91 10.1 88 3.1
52 10.1 107 10.0 103 3.0
53 10.1 81 10.4 78 2.0
54 9.9 101 9.7 104 3.1
55 9.9 61 9.6 65 3.8
56 9.7 111 9.7 112 1.2
Continued
6 Borghans I, Hekkert KD, den Ouden L, et al. BMJ Open 2014;4:e004773. doi:10.1136/bmjopen-2013-004773
Open Access
group.bmj.com on February 27, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
money in the present Dutch ﬁnancing system. Although
the indicator is not developed for ﬁnancial purposes,
the use of the indicator may, as a beneﬁcial side effect,
also reduce the total amount of hospital days.
There are two main limitations to this study.
1. Some hospitals, especially the UMCs, differed from
the national median. The high score for the UMCs
could indicate that there is insufﬁcient adjustment
for the speciﬁc patient categories admitted to the
UMCs. The current indicator adjusts for differences
in age, principal diagnosis and procedures. But there
are probably more variables involved in a prolonged
hospital stay. The case mix adjustment is more
limited than for example the HSMR. Further
research is needed to determine which other patient
characteristics, for example, comorbidity, play a sig-
niﬁcant role in a prolonged length of stay and
whether they are of added value in standardising hos-
pital stay next to the present cofounders.
2. We used a threshold of a length of stay of 50% longer
than expected for the indicator. This threshold was
based on the three aforementioned reasons and
especially our ﬁrst experiences with reviewing hos-
pital records based on length of stay.30 However,
there is no evidence that the threshold has to be
exactly 50%. A more detailed study is needed to
determine the appropriateness of this threshold.
Further research is also needed to determine to what
extent the proportion of patients which crosses the
threshold can vary for each combination of age,
main diagnosis and procedure. If the variations
between hospitals are large, and the case mix clearly
differs, this will present a number of unequal oppor-
tunities that will result in crossing the 50% threshold.
We might need to vary the threshold for different
diagnostic groups.
CONCLUSION
The IGZ introduced the outcome indicator ‘percentage
of patients with a UL-LOS’ for its supervision since 2010.
It is based on the assumption that complications often
prolong the patient’s hospital stay. A higher percentage
of patients with a UL-LOS compared to the national
average, after a correction is made for case mix varia-
tions, may indicate shortcomings in the quality or safety
of care delivered by the hospital. The indicator currently
‘counts’ all patients for whom the actual length of stay
exceeds the expected duration by 50% or more. It needs
to be studied whether this cut-off point can be set separ-
ately for each patient group. The indicator varies system-
atically between hospitals and is rather stable over time.
It correlates with other outcome indicators, which could
indicate the capacity to identify opportunities for
improvement of patient safety.
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